ANRO
Alto Neuroscience, Inc.Closed22.09−2.06 −8.53%USD
NYSE · as of Oct 13, 16:00 ET · 20m delayAfter hours 22.30 +0.95%
Open
24.04
Prev close
24.15
Day range
22.0724.20
52-week range
5.5637.48
Volume
663.30K1.29×
Mkt cap
866.86M
P/E ttm
—
Fwd P/E
-6.72
EPS ttm
-2.31
Div yield
0.00%
Earnings
—
From 52w high
−41.06%
ANRO shareholders
ANRO Ownership
13F / N-PORT filings via Yahoo
Institutions
87.1%
90.9% of the float
Insiders
4.2%
officers and directors
Institutional holders
165
filing positions
Top 10 institutions
44.8%
5 adding · 3 trimming
Top Institutions
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| Alpha Wave Global, LP | 9.45% | 3.71M | $81.90M | 0.0% | Jun 30, 2026 |
| Commodore Capital Lp | 6.94% | 2.72M | $60.16M | 0.0% | Jun 30, 2026 |
| Blackrock Inc. | 5.40% | 2.12M | $46.85M | +218.4% | Jun 30, 2026 |
| Perceptive Advisors Llc | 4.10% | 1.61M | $35.56M | −19.9% | Jun 30, 2026 |
| Adage Capital Partners GP L.L.C. | 4.08% | 1.60M | $35.34M | +315.6% | Jun 30, 2026 |
| Vanguard Capital Management LLC | 3.54% | 1.39M | $30.69M | +15.1% | Jun 30, 2026 |
| Spruce Street Capital LP | 3.45% | 1.35M | $29.89M | +2.1% | Jun 30, 2026 |
| Vivo Capital, LLC | 3.08% | 1.21M | $26.70M | +16.7% | Jun 30, 2026 |
| Franklin Resources, Inc. | 2.58% | 1.01M | $22.38M | −8.0% | Jun 30, 2026 |
| Armistice Capital, LLC | 2.20% | 864.00K | $19.09M | −5.3% | Jun 30, 2026 |
Top Funds
| Holder | % held | Shares | Value | Change | As of |
|---|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.58% | 1.01M | $22.35M | +15.5% | Jun 30, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.69% | 662.27K | $14.63M | +0.7% | Aug 31, 2026 |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 0.89% | 347.90K | $7.69M | −14.2% | Jul 31, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.88% | 346.62K | $7.66M | +14.6% | Jun 30, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.73% | 287.03K | $6.34M | +1.0% | Jul 31, 2026 |
| iShares Trust-iShares Biotechnology ETF | 0.67% | 264.19K | $5.84M | +2.5% | Aug 31, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 0.66% | 259.11K | $5.72M | +20.2% | Aug 31, 2026 |
| iShares Trust-iShares Russell 2000 Growth ETF | 0.62% | 242.25K | $5.35M | +3.3% | Aug 31, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.58% | 228.06K | $5.04M | −15.0% | Jun 30, 2026 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 0.37% | 147.00K | $3.25M | −1.4% | Aug 31, 2026 |
Institutions report quarterly, up to 45 days after the quarter ends, so these positions can be months old. Change compares the share count with the holder's previous filing. Insider transactions are on the overview page (INSD).